The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
Authors
Keywords
Rituximab, Hypogammaglobulinaemia, B cell, Vasculitis, Systemic lupus erythematosus (SLE), IgG, Infection, Autoimmune
Journal
BMC MUSCULOSKELETAL DISORDERS
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-05-25
DOI
10.1186/1471-2474-15-178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center
- (2012) Rodrigo Cartin-Ceba et al. ARTHRITIS AND RHEUMATISM
- Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
- (2012) Rona M. Smith et al. ARTHRITIS AND RHEUMATISM
- Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
- (2012) Carla Casulo et al. Clinical Lymphoma Myeloma & Leukemia
- Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
- (2012) Robert A. Eisenberg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
- (2012) Nils Venhoff et al. PLoS One
- Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations
- (2011) Julia U Holle et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term follow-up of different refractory systemic vasculitides treated with rituximab
- (2011) Frances Rees et al. CLINICAL RHEUMATOLOGY
- Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis
- (2011) C. ROUBAUD-BAUDRON et al. JOURNAL OF RHEUMATOLOGY
- Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis
- (2011) M.-J. C. J. Guerry et al. RHEUMATOLOGY
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- (2010) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- (2010) Erika Irie et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Biological therapy for lupus nephritis—tribulations and trials
- (2010) Rona M. Smith et al. Nature Reviews Rheumatology
- Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus
- (2010) F. Catapano et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis
- (2009) Rachel B. Jones et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- B-cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort study
- (2009) M. Martinez Del Pero et al. CLINICAL OTOLARYNGOLOGY
- Deoxyspergualin in relapsing and refractory Wegener's granulomatosis
- (2008) O Flossmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma
- (2008) L K Hicks et al. BONE MARROW TRANSPLANTATION
- Serum Immunoglobulins and Risk of Infection: How Low Can You Go?
- (2008) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started